Loading
IARC estimates 1,731 new cancer cases and 843 cancer deaths in Fiji in 2024; the commonest new cancers are breast, prostate and cervix uteri. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
Built partly from other countries' data. IARC's method code for Fiji's incidence estimate is 3b: national mortality estimates applied to model-based mortality-to-incidence ratios (neighbouring country registry data). Read the figures as a regional estimate, not a count.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 297 | 59.0 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 228 | 54.5 | Prostate cancer |
| Cervix uteri | 192 | 38.0 | Cervical cancer |
| Colorectum | 136 | 15.0 | Colorectal cancer |
| Thyroid | 109 | 11.2 | Thyroid cancer |
| Liver and intrahepatic bile ducts | 104 | 11.2 | Hepatocellular carcinoma |
| Corpus uteri | 82 | 16.7 | Endometrial cancer |
| Leukaemia | 70 | 7.3 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Trachea, bronchus and lung | 69 | 7.6 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Ovary | 56 | 11.1 | Ovarian cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Breast | 188 | 37.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 114 | 22.9 | Cervical cancer |
| Liver and intrahepatic bile ducts | 76 | 8.2 | Hepatocellular carcinoma |
| Colorectum | 54 | 6.4 | Colorectal cancer |
| Trachea, bronchus and lung | 52 | 5.7 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Prostate | 49 | 13.9 | Prostate cancer |
| Ovary | 34 | 6.9 | Ovarian cancer |
| Leukaemia | 31 | 3.2 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Stomach | 26 | 2.9 | Gastric & gastro-oesophageal junction cancer |
| Pancreas | 23 | 2.6 | Pancreatic ductal adenocarcinoma |
No trial record in OnCo lists a site in Fiji. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Fiji.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Fiji is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Fiji is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.